Sridurga Mithraprabhu

Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma

Sridurga Mithraprabhu, Anna Kalff, Annie Chow et al. · Epigenetics · 2014 · 179 citations · Full text

Medicine, Molecular Biology, Oncology +15

Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma

Sridurga Mithraprabhu, Tiffany Khong, Malarmathy Ramachandran et al. · Leukemia · 2016 · 109 citations

Medicine, Cancer Biology, Oncology +16

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome

Puay Hoon Tan, Andrew H. Wei, Sridurga Mithraprabhu et al. · Blood Cancer Journal · 2014 · 95 citations · Full text

Medicine, Oncology, Pharmacology +16

Activin Bioactivity Affects Germ Cell Differentiation in the Postnatal Mouse Testis In Vivo1

Sridurga Mithraprabhu, Sarah J. Meachem, Laura Tubino et al. · Biology of Reproduction · 2010 · 66 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +15

Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients

Sridurga Mithraprabhu, Rachel Morley, Tiffany Khong et al. · Leukemia · 2019 · 59 citations

Medicine, Molecular Medicine, Oncology +17